Thrombosis
Asim K. DuttaroyERN 3110
HomeostasisState of fluid equilibrium within the blood vessels
Vessels
Platelets
Fibrinolysis/Inhibitors
Coagulation Proteins
Hemostasis
• Arrest of bleeding
• Events preventing excessive blood loss– Vascular spasm: Vasoconstriction of
damaged blood vessels– Platelet plug formation – Coagulation or blood clotting
Functions of Blood
• Transport of: – Gases, nutrients, waste products– Processed molecules– Regulatory molecules
• Regulation of pH and osmosis
• Maintenance of body temperature
• Protection against foreign substances
• Clot formation
Composition of Blood
HEMOSTASIS
VASCULAR SPASM
PLATELET PLUG
BLOOD COAGULATION (will talk later)
GROWTH OF FIBROUS TISSUE IN CLOT
Fibrinolysis (will talk later)
What is thrombosis?
• Thrombosis is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system
• When a thrombus occupies more than 75% of cross-sectional area of the lumen of an artery, blood flow to the tissue supplied is reduced enough to cause of symptoms because of decreased oxygen supply and accumulation of lactic acid.
• More than 90% obstruction can result in anoxi, complete deprivation of oxygen, and the infarction , a mode of cell death
Thrombosis
• Arterial Thrombosis : – Adherence of platelets to arterial walls - White in
color - Often associated with MI, stroke and ischemia
• Venous Thrombosis :– Develops in areas of stagnated blood flow (deep
vein thrombosis), Red in color- Associated with Congestive Heart Failure, Cancer, Surgery.
Slide 3 of 28
Haemostasis:
• Vasoconstriction • Platelet activation• Haemostatic plug• Coagulation• Stable clot formation• Clot dissolution
BLOOD COAGULATION
ThrombinThrombin
FibrinogenFibrinogen Fibrin MonomersFibrin Monomers
Fibrin threadsFibrin threads
CaCa+2+2, factor XIII, factor XIII
Coagulation:
• Fibrinogen to Fibrin – Coag. Cascade
• Several factors – proenzymes-activation.
• Enzyme amplication –
• Plasma, Endothelium & Platelets
• Stable hemostatic plug.
• Clot lysis – starts soon after clot formation.
Haemostasis overview:
BV Injury
PlateletPlateletAggregation
PlateletActivation
Blood VesselBlood Vessel Constriction
CoagulationCoagulation Cascade
Stable Hemostatic Plug
Fibrin formation
Reduced
Blood flow
Contact/ Tissue Factor
Primary hemostatic plug
Neural
formation of the platelet plug
coagulation = fibrin formation
clot retraction
fibrinolysis
RESOLUTION
NORMAL HAEMOSTASIS
platelet and coagulation activation within
blood vessel
PLATELETS AND ARTERIAL THROMBOSIS
Thrombus
“a mass of blood constituents formed within the vascular system”
“inappropriate haemostasis” ?
Overlap of Vascular Disease in Patients With Atherothrombosis
Vascular events (MI, stroke, or CV death)Vascular events (MI, stroke, or CV death)
Plaque Plaque rupturerupture
Platelet Platelet adhesion, adhesion, activation, activation,
and and aggregationaggregation
Thrombus Thrombus formationformation
MIMIUnstable anginaUnstable anginaIschemic strokeIschemic stroke PADPAD
Ness J, Aronow WS. J Am Geriatr Soc. 1999;47:1255-1256. Schafer AI. Am J Med. 1996;101:199-209.
How do we know platelets are important in CVD?
Platelets are present in atherosclerosis, thrombosis, embolism i.e. at early and late stages of cardiovascular disease
Activated platelets are present in circulation of patients with cardiovascular disease
Modification of platelet activity affects the development and progression of cardiovascular disease
What are platelets?
What are Platelets?
Role in Health : how do they work?
Role in Diseasebleeding disordersatherosclerosisarterial thrombosisthrombo-embolism
Platelets in cardiovascular disease
Techniques for the study of platelets
Anti-platelet Therapy in Cardiovascular Disease
Normal Function of Platelets
Haemostasis
• Preventing bleeding from wounds
• Integrity and repair of the vessel wall
Platelets circulate in a resting, inactive state
Must become activated
Must stick together = Aggregation
Haemostatic role of platelets in health: how do they work?
Disk-shaped cellfragments producedin the megakaryocytes
Mature Platelet
Megakaryocyte
BoneMarrow
What are Platelets?
Storage and Circulation
Quantity - 200,000 - 400,000/mm3
Life Span - 10 days33%pooling
67%in the
circulation
MegakaryocyteSpleen
lipid bilayer
Glycoprotein receptors
Fig. 16-10
PlateletPlug Formation
Platelet AggregationFibrinogen binding to Glycoprotein IIb-IIIa on
activated platelets
Factors that activate platelets
ADPThrombinCollagen
5-hydroxytryptamine (serotonin)Thromboxane A2
Mechanical stimuli
Many stimuliSeveral different receptors
Multiple signalling pathways
Adhesion
GpIIb/IIIa
Platelet Activation Pathways
GpIIb/IIIaGpIIb/IIIa Aggregation
ADP
Adrenaline Platelet GpIb
Exposed Collagen
Endothelium
vWF
COLLAGEN
GpIIb/IIIaGpIIb/IIIa AggregationGpIIb/IIIaGpIIb/IIIa Aggregation
AdhesionAdhesion
ADP
Adrenaline
THROMBINTHROMBIN
Slide 23 of 79
Targets for anti-platelet therapy
AspirinNSAIDs
ADPreceptor
COX-1
TXA2
GPIIb - IIIa
Signalling
pathways
ADP receptor antagonistsClopidogrel THROMBIN
receptor
Thrombin inhibitors
II
Fibrinogen
Phosphodiesterase inhibitors
dipyridamole
Fibrinogen Receptor Antagonists
AAAA
PrimaryMetabolic
Disturbance
PrimaryMetabolic
Disturbance
Intermediate Vascular Disease
Risk Factor
Intermediate Vascular Disease
Risk Factor Intravascular
PathologyIntravascular
PathologyClinicalEvent
ClinicalEvent
Atherosclerosis
Hypercoagulability
• Coronary arteries• Carotid arteries• Cerebral arteries• Aorta• Peripheral arteries
Hypertension
Dyslipidemia
Hyperinsulinemia
Hyperglycemia
Inflammation
ImpairedFibrinolysis
Endothelial Dysfunction
Insulin Resistance
CVDOvernutrition
Hyperactivity of Platelets plays central role
Slide 27 of 79
Tissue factor,VIIa
Plaques
Effects of spices on platelet function
Spice Effects on platelets
GarlicReduced TxA2 generation, Reduced AA incorporation to membrane PL
Onion Reduced TXA2 and 12-Lipoxygenase products
Ginger Reduced Aggregation
Cloves
Cumin
TumericReduced TxA2 generation, Reduced AA incorporation to membrane PL
Antiaggregatory, Reduces cyclooxygenase and lipoxygneaseproducts
Inhibits AA-induced Aggregation
In vitro anti-aggregatory properties of fruit extracts
Fruits % of inhibition
Tomato 92
Kiwifruit 85
Strawberries 51-65
Melon 30
Plum 25
Banana 21
Avocado 21
Mango 19
Cranberry 18
Orange 18
Nectarine 15
Pineapple 12
Pear 5
Apple 2
Disorders of platelets
• Decreased Number: Thrombocytopenia– Decreased Production– Decreased Survival – Immune (ITP)– Increased utilization - DIC
• Defective Platelet function:– Acquired – Drugs – Aspirin, MPS, MDS– Congenital – Eg. Thrombasthenia.
Disorders of Hemostasis
• Vascular disorders– Scurvy, easy bruising,
• Platelet disorders– Low Number or abnormal function
• Coagulation disorders– Factor deficiency.
• Mixed/Consumption: DIC
Platelet
Petechiae, Purpura
Role of Platelets in Acute Ischaemic Event1. Growth of atherosclerotic plaque
2. Plaque rupture
3. Thrombus formation
4. Occlusion
NEXT
What techniques can we use to study platelets ?
Modification of platelets in the prevention and treatment of cardiovascular disease
Drugs in current use and some newer ones
How can we study platelets in the laboratory?
FUNCTIONSkin bleeding timeAggregation in vitro - response to added agonistsAssay of Products secreted by activated platelets into plasma, in vitro or in vivo
ACTIVATION STATE OF CIRCULATING PLATELETSFlow Cytometry with fluorescent markers
STRUCTURE - electron microscopy
BIOCHEMICAL PATHWAYS - signalling pathways, phosphorylation, Ca++ influx
Platelet Granule Contentsreleased on activation
Alpha-granules:Beta-thromboglobulinPlatelet Factor 4 Fibrinogenadhesive glycoproteins::P-selectin, vWF, Coagulation Factor VGrowth Factors
Dense Granules:ADP Calcium ions,
ATP Serotonin (5-HT)
Radioimmunoassay
ELISAin plasma
ASSAYS
FluorescenceHPLCradiolabelling
Platelet Function Defects
Aggregation Coagulation
1. Failure of platelets to adhere
2. Failure to release ADP
3. Failure to release TxA2
4. Failure to aggregate
5. Failure of surface binding of coagulation factors
Shape Change Release Delayed Fibrin Formation
Adhesion
Diagnostic Procedures
• Platelet count
• Peripheral smear
• Platelet aggregation
• Bleeding time
• Platelet adhesiveness
• Clot retraction
Drugs That Affect Platelets
• Analgesics (aspirin, NSAIDs) affecting prostanoid synthesis or action
• Caffeine, theophylline, dipyridamole and drugs which increase platelet cyclic AMP
• Antimicrobials (penicillins, cephalosporins, nitrofurantoin)
• Cardiovascular agents (quinidine, diurectics, vasodilators
• Anticoagulants (coumadin, heparin) and Thrombolytics (t-PA, streptokinase)
• Psychotropics (tricyclics/phenothiazines) and anesthetics
• Chemotherapeutic agents
• Miscellaneous agents (dextrans, clofibrate, ETOH, Vitamin E, onions, garlic, ginger, fish oil)
Plaetelet aggregation can be measured in
Platelet rich plasma (PRP): Blood collected in citrate bufferand centrifuged at 200xg for 10 min,PRP is used to measure platelet aggregation
Washed platelets: plasma proteins are removed from PRP byColumn chromatography or centrifugation
Whole blood aggregation: blood is used as such with or without dilution
In vitro platelet aggregation is an effort to charatcerise the in vivo ability if the platelets to form the primary hemostatic plug
Whole blood aggregation: by which platelets are tested in anti-coagulated blood, without the need to islolate them from other components of blood.
The chrono-log whole blood aggregometer consists of sample Compartments heated to 37C with stiring facility using magnetic bars
Principle of whole blood aggregation:
Impedence method (electrical resistance)
Two electrodes are inserted in blood sample (0.5 ml) at 37C.
Platelet monolayer is developed on the electrode surface and basal resistance is developed.
As platelet aggregation proceeds with the addition of agonist the more platelets aggregates
are deposited on the electrodes, and the resistance (ohm) is increased
Disadvantages of some techniques
Require large sample of fresh blood Susceptible to ex vivo activation during venepuncture and sample preparation, particularly centrifugation or washing Take a long time to perform Better at detecting hypo-functional platelets (bleeding disorders) than hyper-active platelets (pro-thrombotic)
Dutta-Roy, AK, Dietary components and human platelet activity. Platelets. 2002 Mar;13(2):67-75..
Dutta-Roy, AK Effects of tomato extract on human platelet aggregation in vitro Platelets. 2001 12:218-27
Andrews and Berndt Platelet physiology and thrombosis. Thromb Res. 2004;114(5-6):447-53
Kroll MH, Schafer AI. Biochemical mechanism of platelet activation Blood 1989; 74: 1181-95.
Colquhoun DM, Nutraceuticals: vitamins and other nutrients in coronary heart disease, Curr Opin Lipidol , 2001, 12, :639-46
Top Related